Compare · RETO vs TMO
RETO vs TMO
Side-by-side comparison of ReTo Eco-Solutions Inc. (RETO) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RETO and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.53B, about 37493.5x RETO ($6.9M).
- TMO has been more active in the news (7 items in the past 4 weeks vs 3 for RETO).
- TMO has more recent analyst coverage (25 ratings vs 0 for RETO).
- Company
- ReTo Eco-Solutions Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $6.9M
- $257.53B
- 1M return
- -78.17%
- -
- 1Y return
- -99.79%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 3
- 7
- Recent ratings
- 0
- 25
ReTo Eco-Solutions Inc.
ReTo Eco-Solutions, Inc., together with its subsidiaries, manufactures and distributes construction materials primarily in China. Its products include aggregates, bricks, pavers, and tiles. The company's construction materials are used for water absorption, flood control, and water retention; for gardens, roads, bridges, city squares, retaining walls, and slope construction; for hydraulic ecological projects, such as slope protection and river transformation; and for insulation, decoration, and building walls. It also offers construction materials manufacturing equipment, such as automated production equipment with hydraulic integration in China, South Asia, North America, the Middle East, North Africa, and Southeast Asia. In addition, the company undertakes municipal construction projects, including sponge city projects, sewage pipeline construction, public plaza construction, and landscaping. It also exports its products. ReTo Eco-Solutions, Inc. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest RETO
- ReTo Eco-Solutions, Inc. Announces Share Consolidation
- SEC Form 6-K filed by ReTo Eco-Solutions Inc.
- SEC Form 424B5 filed by ReTo Eco-Solutions Inc.
- SEC Form 6-K filed by ReTo Eco-Solutions Inc.
- Univest Securities, LLC Announces Closing of $15.0 Million Registered Direct Offering for its Client ReTo Eco-Solutions, Inc. (NASDAQ: RETO)
- SEC Form 424B5 filed by ReTo Eco-Solutions Inc.
- ReTo Eco-Solutions, Inc. Announces Pricing of $15 Million Registered Direct Offering
- SEC Form SEC STAFF ACTION filed by ReTo Eco-Solutions Inc.
- SEC Form 6-K filed by ReTo Eco-Solutions Inc.
- SEC Form 424B5 filed by ReTo Eco-Solutions Inc.
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)